Middle East And Africa Fecal Occult Blood Tests Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
USD 90.88 million |
 Market Size (Forecast Year) |
USD 90.88 million |
 CAGR |
% |
| Major Markets Players |
>中东和非洲粪便潜血检测市场，按检测类型（横向流动免疫 FOB 检测试剂盒、免疫 FOB 凝集检测试剂盒、免疫 FOB ELISA 检测试剂盒、愈创木脂 FOB 粪便检测、可冲洗试剂垫或组织等）、应用（结直肠癌筛查、对胃肠道出血、息肉、憩室病、溃疡、痔疮、结肠炎、贫血等的关注）、最终用户（诊断实验室、医院、专科诊所等）、分销渠道（直销、零售、电子商务等）划分 - 行业趋势和预测到 2030 年。
中东和非洲粪便潜血检测市场分析和规模
推动粪便潜血检测市场增长的主要因素之一是中东和非洲结肠直肠癌病例的增加。多家公司为更好地诊断而进行的持续临床试验研究推动了市场扩张。直接面向消费者的实验室检测的发展以及粪便潜血免疫测试设备在网上商店的普及也影响了市场。
中东和非洲粪便潜血检测市场预计将在 2023 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场将以 4.4% 的复合年增长率增长，预计到 2030 年将达到 9088 万美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按检测类型（横向流动免疫 FOB 检测试剂盒、免疫 FOB 凝集检测试剂盒、免疫 FOB ELISA 检测试剂盒、愈创木脂 FOB 粪便检测、可冲洗试剂垫或组织等）、应用（结直肠癌筛查、关注胃肠道出血、息肉、憩室病、溃疡、痔疮、结肠炎、贫血等）、最终用户（诊断实验室、医院、专科诊所等）、分销渠道（直销、零售、电子商务等） |
|
覆盖国家 |
南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区 |
|
涵盖的市场参与者 |
Biopanda Reagents Ltd、HUMASIS.COM、CTK Biotech, Inc.、Biohit Oyj、CERTEST BIOTEC、Alfa Scientific Designs, Inc.、Cenogenics Corporation、Jant Pharmacal Corporation、Quidel Corporation、Wondfo.、Siemens Healthcare GmbH 等 |
市场定义
粪便潜血试验 (FOBT) 是一种诊断性筛查试验，用于分析粪便样本中的隐藏（潜）血。粪便潜血试验通常也称为粪便潜血、免疫测定 FOBT、血潜血、IFOBT 和愈创木脂涂片试验。该试验主要用于筛查结肠癌和分析不明原因贫血的可能原因。
粪便潜血检测市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
驱动程序
- 中东和非洲结直肠癌病例不断增加
结直肠癌是一种结肠或直肠疾病，结肠或直肠是消化系统的一部分。与大多数癌症不同，结直肠癌通常可以通过筛查预防，并且如果及早发现则可以治疗。大多数结直肠癌病例发生在 45 岁及以上的人群中。由于不卫生的生活方式和吸烟习惯，这种疾病越来越影响年轻人。结直肠癌可能没有症状。常见症状可能包括粪便中或粪便上带血、持续排便异常（如便秘或腹泻）、胃痛、持续时间较长的疼痛或痉挛以及无缘无故的体重减轻。
大多数结直肠癌都是从结肠或直肠内异常组织生长（称为息肉）开始的。医生可以通过筛查检测发现息肉，并将其切除，防止其发展为结直肠癌。即使息肉扩散到附近的淋巴结，化疗和手术治疗也是治疗结直肠癌的有效方法。研究正在进行中，以更多地了解这种疾病，并为所有阶段的结直肠癌患者提供更多希望。
- 直接面向消费者的实验室测试
直接面向消费者的实验室检测是一种有效的方式，用户可以直接从实验室订购相应的实验室检测，而无需任何医疗保健提供者。如今，医疗保健行业正在从基于医生的实验室检测转向直接面向消费者的实验室检测，因此需求急剧增加。大多数患者都专注于直接面向消费者的实验室检测，而无需经过漫长的临床流程，这推动了粪便潜血检测市场的增长。
检测结果可用于识别以前未知的疾病。直接面向消费者的实验室检测领域的进步对于提高患者参与度以更好地监测和筛查现有健康状况至关重要。因此，实验室专业人员升级检测实验室使用的设备和仪器非常重要。
-
粪便潜伏免疫学检测设备在网上商店很容易买到
粪便潜血检测 (FOBT) 通常针对粪便样本进行血液检测。粪便中出现血液表示消化道出血。出血可能是由多种疾病引起的，如息肉（结肠或直肠内壁异常生长）、痔疮（肛门或直肠静脉肿胀）、憩室病（结肠内壁出现小囊的疾病）、溃疡（消化道内壁溃疡）、结肠炎（一种炎症性肠病）和结直肠癌。
市场上有大量粪便潜血免疫测试设备，人们可以从各种在线网站购买试剂盒和设备。因此，这可能是粪便潜血测试市场增长的一个驱动因素。
机会
-
增加筛查程序
大多数政府机构和科学协会都建议进行宫颈癌、乳腺癌和结直肠癌筛查，因为这些癌症的负担较重、筛查检测较为便捷，而且筛查在降低宫颈癌和结直肠癌的死亡率和发病率方面已被证实有效。
欧洲共同体建议实施以人群为基础的结肠直肠癌筛查计划。许多观察性研究支持这一建议，这些研究表明，有组织的计划可有效降低死亡率并控制筛查测试的不当使用。
-
技术进步不断进步
血液检测一直是一个依赖技术和数据的领域。由于数据和技术有可能彻底改变诊断服务，因此我们有能力与患者、家庭、从业者、研究人员、行业领导者、政策制定者和管理人员合作，以确保人性化、高价值、不断改进的精准诊断仍然是血液检测诊断未来的核心目标。
粪便潜血检测的用途已扩展到多种适应症，尽管其主要用途是评估胃肠道失血的隐匿来源和结肠直肠癌筛查的家庭试剂盒。粪便潜血检测最常见的临床用途之一是在抗凝治疗前检查粪便样本是否有隐匿性出血。
限制/挑战
- 消费者偏好转向更具成本效益的替代品
粪便潜血检测产品价格昂贵，通常不是每个人都能负担得起。随着技术日益先进，市场上有许多检测替代品可供选择。因此，人们更喜欢经济实惠的粪便潜血检测替代品。各种筛查计划通常针对看似健康的人，使用筛查服务的人数通常高于实际患者人数。粪便潜血检测比结肠镜检查更具优势，因为它成本较低且易于操作。
由于市场上有大多数粪便潜血检测替代品。因此，人们更喜欢成本更低、结果更准确的替代品。因此，消费者对具有成本效益的替代品的偏好转变可能会抑制预测期内的市场增长。
- 效率低下
粪便潜血检测并不总是准确的，当存在癌症时可能显示阴性检测结果，如果癌症或息肉没有出血，则会出现假阴性结果。
当患者没有癌症（假阳性结果）或有其他来源的出血，例如胃溃疡、痔疮，甚至从口或鼻吞下的血液时，测试可能会显示阳性结果。
新冠肺炎疫情对粪便潜血检测市场的影响
COVID-19 疫情对粪便潜血检测行业产生了巨大影响。结直肠癌和胃肠道出血诊断产品行业的贸易团体声称，中东和非洲的诊断产品供应链已严重受损，影响了粪便潜血检测市场的终端用户消费。由于物流和运输问题，2020 年第一季度的检测产品销售大幅延迟。在需求方面，由于封锁结束后人们必须接受诊断，市场正在增长。需要考虑这种情况，并需要进行紧急诊断。此外，在供应方面，市场的增长呈负增长。这是由于许多生产诊断、手术和癌症护理以及粪便潜血检测仪器的国家处于封锁状态。
最新动态
- 2022 年 11 月，荣研化学有限公司推出了全自动粪便免疫化学检测/粪便钙卫蛋白分析仪“OC-SENSOR Ceres”。这有助于该公司在中东和非洲建立其产品
- 2022 年 1 月，Boditech Med Inc. 宣布已与 A. Menarini Diagnostics 签署了一份价值 1920 万美元的供应协议，以加速其产品组合。这有助于该组织创造收入
中东和非洲粪便潜血检测市场范围
中东和非洲粪便潜血检测市场根据检测类型、应用、最终用户和分销渠道分为四个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
测试类型
- 横向流动免疫-FOB测试套件
- 免疫FOB凝集检测试剂盒
- 免疫-FOB ELISA 检测试剂盒
- 愈创木脂 FOB 粪便检测
- 可冲洗试剂垫或纸巾
- 其他的
根据测试类型，中东和非洲粪便潜血检测市场分为侧流免疫-FOB 测试试剂盒、免疫-FOB 凝集测试试剂盒、免疫-FOB ELISA 测试试剂盒、愈创木脂 FOB 粪便测试、可冲洗试剂垫或组织等。
应用
- 结直肠癌筛查
- 担心胃肠道出血
- 息肉
- 憩室病
- 溃疡
- 痔疮
- 结肠炎
- 贫血
- 其他的
根据应用，中东和非洲粪便潜血检测市场分为结直肠癌筛查、胃肠道出血、息肉、憩室病、溃疡、痔疮、结肠炎、贫血等。
最终用户
- 诊断实验室
- 医院
- 专科诊所
- 其他的
根据最终用户，中东和非洲粪便潜血检测市场分为诊断实验室、医院、专科诊所和其他。
分销渠道
- 直接招标
- 零售销售
- 电子商务
- 其他的
根据分销渠道，中东和非洲粪便潜血检测市场分为直接招标、零售、电子商务和其他。
粪便潜血检测市场区域分析/见解
对粪便潜血检测市场进行了分析，并按国家、检测类型、应用、最终用户、分销渠道提供了市场规模洞察和趋势，如上所述。
中东和非洲粪便潜血检测市场包括南非、沙特阿拉伯、阿联酋、埃及、以色列和中东和非洲其他地区。
由于对即时诊断的偏好日益增加，南非有望在中东和非洲粪便潜血检测市场占据主导地位。粪便潜血检测产品需求的增加以及行业研发活动的增加也有望在预测期内推动市场发展。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战，以及销售渠道的影响。
竞争格局和中东和非洲粪便潜血检测市场份额分析
粪便潜血检测市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与专注于中东和非洲粪便潜血检测市场的公司有关。
该市场的一些主要参与者包括 Biohit Oyj、Wondfo.、Epitope Diagnostics, Inc.、Accuquik Test Kits、Apacor Limited、Quidel Corporation.、Siemens Healthcare GmbH 和 Eiken Chemical Co., Ltd. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 MARKET APPLICATION COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S 5 FORCES
5 INDUSTRY INSIGHTS
6 REGULATORY FRAMEWORK
6.1 REGULATORY SCENARIO BY U.S. FDA
6.2 REGULATORY SCENARIO IN U.S.
6.3 REGULATORY SCENARIO IN EUROPE
6.4 REGULATORY SCENARIO IN CANADA
6.5 REGULATORY SCENARIO IN AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING CASES OF COLORECTAL CANCER MIDDLE EAST & AFRICALY
7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING
7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES
7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS
7.2 RESTRAINTS
7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES
7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES
7.3 OPPORTUNITIES
7.3.1 INCREASE IN SCREENING PROCEDURES
7.3.2 RISING TECHNICAL ADVANCEMENTS
7.3.3 STRATEGIC INITIATIVES
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS
7.4.2 LOW EFFICIENCY
8 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE
8.1 OVERVIEW
8.2 LATERAL FLOW IMMUNO-FOB TEST KITS
8.3 IMMUNO-FOB AGGLUTINATION TEST KITS
8.4 IMMUNO-FOB ELISA TEST KITS
8.5 GUAIAC FOB STOOL TEST
8.5.1 KITS
8.5.1.1 GUAIAC SLIDES
8.5.1.1.1 25 PACKAGE
8.5.1.1.2 20 PACKAGE
8.5.1.1.3 OTHERS
8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER
8.5.1.2.1 SENSITIVITY IS 50NG/ML
8.5.1.2.1.1 25 PACKAGE
8.5.1.2.1.2 20 PACKAGE
8.5.1.2.1.3 OTHERS
8.5.1.2.2 SENSITIVITY IS 75NG/ML
8.5.1.2.2.1 25 PACKAGE
8.5.1.2.2.2 20 PACKAGE
8.5.1.2.2.3 OTHERS
8.5.1.2.3 OTHERS
8.5.1.3 OTHERS
8.5.2 REAGENTS
8.5.2.1 HYDROGEN PEROXIDE
8.5.2.2 OTHERS
8.6 FLUSHABLE REAGENT PAD OR TISSUE
8.7 OTHERS
9 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 COLORECTAL CANCER SCREENING
9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.2.3 IMMUNO-FOB ELISA TEST KITS
9.2.4 GUAIAC FOB STOOL TEST
9.2.5 FLUSHABLE REAGENT PAD OR TISSUE
9.2.6 OTHERS
9.3 CONCERN FOR GASTROINTESTINAL BLEEDING
9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.3.3 IMMUNO-FOB ELISA TEST KITS
9.3.4 GUAIAC FOB STOOL TEST
9.3.5 FLUSHABLE REAGENT PAD OR TISSUE
9.3.6 OTHERS
9.4 POLYPS
9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.4.3 IMMUNO-FOB ELISA TEST KITS
9.4.4 GUAIAC FOB STOOL TEST
9.4.5 FLUSHABLE REAGENT PAD OR TISSUE
9.4.6 OTHERS
9.5 DIVERTICULOSIS
9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.5.3 IMMUNO-FOB ELISA TEST KITS
9.5.4 GUAIAC FOB STOOL TEST
9.5.5 FLUSHABLE REAGENT PAD OR TISSUE
9.5.6 OTHERS
9.6 ULCERS
9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.6.3 IMMUNO-FOB ELISA TEST KITS
9.6.4 GUAIAC FOB STOOL TEST
9.6.5 FLUSHABLE REAGENT PAD OR TISSUE
9.6.6 OTHERS
9.7 HAEMORRHOIDS
9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.7.3 IMMUNO-FOB ELISA TEST KITS
9.7.4 GUAIAC FOB STOOL TEST
9.7.5 FLUSHABLE REAGENT PAD OR TISSUE
9.7.6 OTHERS
9.8 COLITIS
9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.8.3 IMMUNO-FOB ELISA TEST KITS
9.8.4 GUAIAC FOB STOOL TEST
9.8.5 FLUSHABLE REAGENT PAD OR TISSUE
9.8.6 OTHERS
9.9 ANEMIA
9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS
9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS
9.9.3 IMMUNO-FOB ELISA TEST KITS
9.9.4 GUAIAC FOB STOOL TEST
9.9.5 FLUSHABLE REAGENT PAD OR TISSUE
9.9.6 OTHERS
9.1 OTHERS
10 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER
10.1 OVERVIEW
10.2 DIAGNOSTIC LABORATORIES
10.3 HOSPITALS
10.4 SPECIALITY CLINICS
10.5 OTHERS
11 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALE
11.4 E-COMMERCE
11.5 OTHERS
12 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY REGION
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 U.A.E.
12.1.4 EGYPT
12.1.5 ISRAEL
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 QUIDEL CORPORATION
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 WONDFO.
15.2.1 COMPANY SNAPSHOT
15.2.2 COMPANY SHARE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 SIEMENS HEALTHCARE GMBH
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 RODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 EIKEN CHEMICAL CO., LTD.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 BIOHIT OYJ
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ACCUBIOTECH CO LTD
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 ACCUQUIK TEST KITS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 AIDIAN
15.8.1 COMPANY PROFILE
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ALFA SCIENTIFIC DESIGNS, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 APACOR LIMITED
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 BIOPANDA REAGENTS LTD
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BODITECH MED INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CENOGENICS CORPORATION
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 CERTEST BIOTEC.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 CTK BIOTECH, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 EDP BIOTECH
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 1.16.3 RECENT DEVELOPMENT
15.17 EPITOPE DIAGNOSTICS, INC.
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 EUROLYSER DIAGNOSTICA GMBH
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 FIRSTEP
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 HANGZHOU CLONGENE BIOTECH CO., LTD
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 HUMASIS.COM
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 JANT PHARMACAL CORPORATION
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
15.23 PRIMA LAB SA
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 46 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 47 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 49 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 50 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 52 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 53 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 55 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 56 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 58 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 59 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 61 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 62 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 63 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 64 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 65 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 66 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 67 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 68 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 MIDDLE EAST AND AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 MIDDLE EAST AND AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 MIDDLE EAST AND AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 MIDDLE EAST AND AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 MIDDLE EAST AND AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 MIDDLE EAST AND AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 MIDDLE EAST AND AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 MIDDLE EAST AND AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 78 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 79 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 80 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 81 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 82 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 83 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 84 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 85 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 86 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 87 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 88 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 89 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 90 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 91 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 92 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 93 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 94 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 95 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 96 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 97 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 98 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 99 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 100 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 101 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 102 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 103 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 SOUTH AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 SOUTH AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 SOUTH AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 SOUTH AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 SOUTH AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 SOUTH AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 SOUTH AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 SOUTH AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 112 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 113 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 114 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 115 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 116 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 117 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 118 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 119 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 120 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 121 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 122 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 123 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 124 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 125 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 126 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 127 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 128 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 129 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 130 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 131 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 132 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 133 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 134 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 135 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 136 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 137 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 138 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 SAUDI ARABIA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 SAUDI ARABIA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 SAUDI ARABIA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 SAUDI ARABIA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 SAUDI ARABIA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 SAUDI ARABIA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 SAUDI ARABIA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 146 SAUDI ARABIA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 147 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 148 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 149 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 150 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 151 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 152 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 153 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 154 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 155 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 156 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 157 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 158 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 159 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 160 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 161 U.A.E. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 162 U.A.E. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 163 U.A.E. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 164 U.A.E. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 165 U.A.E. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 166 U.A.E. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 167 U.A.E. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 168 U.A.E. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 169 U.A.E. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 170 U.A.E. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 171 U.A.E. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 172 U.A.E. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 173 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 U.A.E. COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 U.A.E. CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 U.A.E. POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 U.A.E. DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 U.A.E. ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 U.A.E. HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 U.A.E. COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 181 U.A.E. ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 182 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 183 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 185 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 186 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 187 EGYPT GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 188 EGYPT GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 189 EGYPT GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 190 EGYPT KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 191 EGYPT KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 192 EGYPT KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 193 EGYPT GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 194 EGYPT GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 195 EGYPT GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 196 EGYPT ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 197 EGYPT ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 198 EGYPT ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 199 EGYPT SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 200 EGYPT SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 201 EGYPT SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 202 EGYPT SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 203 EGYPT SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 204 EGYPT SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 205 EGYPT REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 206 EGYPT REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 207 EGYPT REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 208 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 EGYPT COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 210 EGYPT CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 EGYPT POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 EGYPT DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 EGYPT ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 EGYPT HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 EGYPT COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 216 EGYPT ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 217 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 218 EGYPT FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 219 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 220 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 221 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 222 ISRAEL GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 223 ISRAEL GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 224 ISRAEL GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 225 ISRAEL KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 226 ISRAEL KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 227 ISRAEL KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 228 ISRAEL GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 229 ISRAEL GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 230 ISRAEL GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 231 ISRAEL ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 232 ISRAEL ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 233 ISRAEL ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 234 ISRAEL SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 235 ISRAEL SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 236 ISRAEL SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 237 ISRAEL SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 238 ISRAEL SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 239 ISRAEL SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 240 ISRAEL REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 241 ISRAEL REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT)
TABLE 242 ISRAEL REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP)
TABLE 243 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 ISRAEL COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 ISRAEL CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 ISRAEL POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 ISRAEL DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 ISRAEL ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 ISRAEL HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 ISRAEL COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 ISRAEL ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 252 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 ISRAEL FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 254 REST OF MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION
FIGURE 11 RISING CASES OF COLORECTAL CANCER MIDDLE EAST & AFRICALY AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030
FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET
FIGURE 14 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022
FIGURE 19 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022
FIGURE 23 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 27 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022)
FIGURE 31 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022)
FIGURE 32 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 33 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 34 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: TEST TYPE (2023-2030)
FIGURE 35 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
